Prostate cancer, is PSA enough for screening?

As the United States suspended PSA screening, the result was an increase in metastatic prostate cancer in men over 75. But is this consideration enough to think of instituting a population screening, which does not exist in our country? No, it’s certainly not enough, but a reasoning must be made, considering that prostate cancer is the most common among men, and is the third cause of cancer death in Europe in men.